Posted by Michael Wonder on 31 Aug 2021
Price relief as epilepsy drug PBS listed
1 September 2021 - Australian epilepsy sufferers will now be reimbursed for a drug that reduces uncontrolled seizures, as a Melbourne mother opens up on her son's "scary" diagnosis.
Lacosamide, also sold under the brand name Vimpat, was listed on the Pharmaceutical Benefits Scheme on Wednesday as an add-on treatment for primary generalised tonic-clonic seizures.
